These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21167355)

  • 1. Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease.
    Alsheikh-Ali AA; Trikalinos TA; Ruthazer R; Terrin N; Wong JB; Sarnak MJ; Estes NA; Kent DM
    Am Heart J; 2011 Jan; 161(1):204-209.e1. PubMed ID: 21167355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator.
    Bruch C; Bruch C; Sindermann J; Breithardt G; Gradaus R
    Europace; 2007 Aug; 9(8):681-6. PubMed ID: 17507354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk stratification and prevention of sudden death in patients with heart failure].
    Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A
    Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for sudden death in heart failure.
    Farwell D; Gollob MH
    Minerva Cardioangiol; 2007 Jun; 55(3):379-84. PubMed ID: 17534256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality.
    Goldenberg I; Moss AJ
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1281-3. PubMed ID: 18775038
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
    Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
    Marijon E; Trinquart L; Otmani A; Leclercq C; Fauchier L; Chevalier P; Klug D; Defaye P; Lellouche N; Mansourati J; Deharo JC; Sadoul N; Anselme F; Maury P; Davy JM; Extramiana F; Hidden-Lucet F; Probst V; Bordachar P; Mansour H; Chauvin M; Jouven X; Lavergne T; Chatellier G; Le Heuzey JY;
    Am Heart J; 2010 Apr; 159(4):659-664.e1. PubMed ID: 20362726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
    Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects].
    Trappe HJ
    Biomed Tech (Berl); 2002 Oct; 47(9-10):243-9. PubMed ID: 12369212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification.
    Piepoli MF; Capucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):325-33. PubMed ID: 17534251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden death prophylaxis in heart failure.
    Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
    Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method to predict the proportional risk of sudden cardiac death in heart failure: Derivation of the Seattle Proportional Risk Model.
    Shadman R; Poole JE; Dardas TF; Mozaffarian D; Cleland JG; Swedberg K; Maggioni AP; Anand IS; Carson PE; Miller AB; Levy WC
    Heart Rhythm; 2015 Oct; 12(10):2069-77. PubMed ID: 26142301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death risk stratification in patients with heart failure.
    Lorvidhaya P; Addo K; Chodosh A; Iyer V; Lum J; Buxton AE
    Heart Fail Clin; 2011 Apr; 7(2):157-74, vii. PubMed ID: 21439495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.